Catalyst Wire Dossier Catalyst Wire Dossier

Clonal Fetal Mesenchymal Stem Cells (cfMSCs)

· Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clonal Fetal Mesenchymal Stem Cells (cfMSCs), covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders [Phase 1]

See pricing